Transcatheter Mitral Valve Implantation (TMVI) Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
Transcatheter Mitral Valve Implantation (TMVI) Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
Summary
GlobalData's Medical Devices sector report, “Transcatheter Mitral Valve Implantation (TMVI) Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update provides comprehensive information about the Transcatheter Mitral Valve Implantation (TMVI) pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
The Transcatheter Heart Valve is an artificial heart valve made up of natural tissue (biological material mainly derived from cow or bovine) surrounded by a flexible mesh frame known as stent (made of steel or cobalt-chromium), all placed in a long narrow tube known as a catheter. The catheter is inserted into a large blood vessel in the groin area (transfemoral) or through a small incision in chest (transapical). Once inside the heart, the valve can then be opened into its natural position by inflation of a balloon and deployed within the patient's diseased mitral valve.
Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
Extensive coverage of the Transcatheter Mitral Valve Implantation (TMVI) under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Transcatheter Mitral Valve Implantation (TMVI) and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment / industry
Reasons to Buy
The report enables you to -
Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
Identify and understand important and diverse types of Transcatheter Mitral Valve Implantation (TMVI) under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product’s current stage of development, territory and estimated launch date
7.9 Aug 31, 2023: Venus Medtech Hangzhou Announces Interim Results for the Six Months Ended June 30, 2023
7.1 Aug 28, 2023: Edwards Lifesciences to Present at the 2023 Wells Fargo Healthcare Conference
7.11 Aug 26, 2023: Medtronic Q2 2024 Earnings Estimates Increased by William Blair
7.12 Aug 08, 2023: Medtronic to Announce Financial Results for its First Quarter of Fiscal Year 2024
7.13 Aug 06, 2023: Voluntary Announcement Self-Developed TMVR System Achieved Excellent Follow-up Results in Multiple Clinical Application Cases
7.14 Jun 08, 2023: Venus Medtech Hangzhou Notice of 2022 Annual General Meeting
7.15 Jun 02, 2023: Venus Medtech Hangzhou proposes a change of auditors, adoption of the share option scheme and resignation of joint company secretary and chief financial officer
7.16 May 11, 2023: Medtronic to announce financial results for its fourth quarter and full fiscal year 2023
7.17 Apr 12, 2023: Medtronic has a layoff in California
8 Appendix
8.1 Methodology
8.2 About GlobalData
8.3 Contact Us
8.4 Disclaimer
2.1 List of Tables
Table 1: Transcatheter Mitral Valve Implantation (TMVI) - Pipeline Products by Stage of Development
Table 17: Tendyne Bioprosthetic Mitral Valve Implantation System - Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation
Table 18: Tendyne Bioprosthetic Mitral Valve Implantation System - Real World Study of the Tendyne Mitral Valve System to Treat Mitral Regurgitation (RESOLVE-MR) (Tendyne PMCF Study)
Table 19: Tendyne Bioprosthetic Mitral Valve Implantation System - Tendyne European Experience Registry
Table 27: Cardiovalve Transfemoral Mitral Valve System - Cardiovalve Transfemoral Mitral Valve System in Patients at High Surgical Risk with Severe Mitral Regurgitation
Table 28: Cardiovalve Transfemoral Mitral Valve System - Early Feasibility Study of the Cardiovalve System for Tricuspid Regurgitation
Table 29: Cardiovalve Transfemoral Mitral Valve System - Early Feasibility Study of the Cardiovalve Transfemoral Mitral Valve System
Table 30: Cardiovalve Transfemoral Mitral Valve System - European Feasibility Study of High Surgical Risk Patients with Severe Mitral Regurgitation Treated with the Cardiovalve Transfemoral Mitral Valve System: AHEAD Study
Table 31: Cardiovalve Transfemoral Mitral Valve System - Evaluation of a Transcatheter Mitral Valve Replacement System for the Treatment of Severe Mitral Regurgitation with High Surgical Risk: A Chinese Feasibility Study
Table 51: FORTIS Mitral Transcatheter Heart Valve - Early Feasibility Study of the Edwards EVOQUE Transcatheter Mitral Valve Replacement System For the Treatment of Moderate to Severe Mitral Regurgitation
Table 52: CardiAQ Mitral Valve - Early Feasibility Study of the Edwards EVOQUE Transcatheter Mitral Valve Replacement System For the Treatment of Moderate to Severe Mitral Regurgitation
Table 53: SAPIEN M3 - SAPIEN M3 System Transcatheter Mitral Valve Replacement Via Transseptal Access
Table 54: EVOQUE Mitral Eos Valve Replacement Device - Early Feasibility Study of the Edwards EVOQUE Transcatheter Mitral Valve Replacement System For the Treatment of Moderate to Severe Mitral Regurgitation
Table 79: Intrepid Transcatheter Mitral Valve Replacement - An Early Feasibility Study of Intrepid Transcatheter Mitral Valve Replacement System in Patients with Severe, Symptomatic Mitral Regurgitation
Table 80: Intrepid Transcatheter Mitral Valve Replacement - Transcatheter Mitral Valve Replacement with the Medtronic Intrepid TMVR System in Patients with Severe Symptomatic Mitral Regurgitation - APOLLO Trial
Table 81: Intrepid Transcatheter Mitral Valve Replacement - Transcatheter Mitral Valve Replacement With the Medtronic Intrepid TMVR Transfemoral System in Patients With Severe Symptomatic Mitral Regurgitation - APOLLO-EU Trial
Table 116: Shanghai Shenqi Medical Technology Co Ltd - Ongoing Clinical Trials Overview
Table 117: SQ-Kyrin Transcatheter Edge-to-Edge Valve Repair System - A Prospective, Multicenter, Single Arm Clinical Trial to Evaluate the Safety and Effectiveness of Transcatheter Mitral Valve Clip Delivery System and Steerable Guide Catheter in Patients with Moderate-severe or Severe Functional MR (FMR)
Table 118: SQ-Kyrin Transcatheter Edge-to-Edge Valve Repair System - SQ-Kyrin Transcatheter Mitral Valve Repair System Feasibility Study
Table 119: Sino Medical Sciences Technology Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 128: Tioga Medical Inc - Ongoing Clinical Trials Overview
Table 129: Transcatheter Mitral Valve Replacement Device - Evaluation of Safety and Feasibility of the Tioga TMVR System for Treatment of Mitral Regurgitation